BX-912 is a direct, selective, and ATP-competitive PDK1 inhibitor (IC50=26 nM). BX-912 blocks PDK1/Akt signaling in tumor cells and inhibits the anchorage-dependent growth of a variety of tumor cell lines in culture or induces apoptosis[1].
Molecular Weight:
471.35
Purity:
99.13
CAS Number:
[702674-56-4]
Formula:
C20H23BrN8O
Target:
Apoptosis,PDK-1
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted